Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings, 10583 [2017-02961]
Download as PDF
Federal Register / Vol. 82, No. 29 / Tuesday, February 14, 2017 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
Contact Person: Cristina Backman, Ph.D.,
Scientific Review Officer, ETTN IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7846, Bethesda, MD 20892, cbackman@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 9, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02962 Filed 2–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Clinical Trials Review.
Date: March 22, 2017.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3An.12N, 45 Center
Drive, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, 301–594–3907, pikbr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
VerDate Sep<11>2014
16:48 Feb 13, 2017
Jkt 241001
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: February 8, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02915 Filed 2–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The [[[ REASON TO
CLOSE TEXT IS MISSING ]]] and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the [[[
REASON TO CLOSE TEXT IS MISSING
]]], the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel.
Date: March 3, 2017.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Bethesda North Marriott Hotel and
Conference Center, Bethesda, MD 20892750.
Contact Person: Minki Chatterji, Scientific
Review Administrator, Division of Scientific
Review, National Institute of Child Health
and Human Development, 6710B Bethesda
Drive, Bethesda, MD 20892, 301.806.2515,
chatterm@csr.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Best Pharmaceutical
for Children Act (BPCA) Data Coordinating
Center (DCC).
Date: April 11, 2017.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6710
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Administrator,
Division of Scientific Review, National
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
10583
Institute of Child Health and Human
Development, 6710B Bethesda Drive,
Bethesda, MD 20892, (301) 435–6680,
skandasa@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Center for Public
Information on Population Research.
Date: May 5, 2017.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Minki Chatterji, Scientific
Review Administrator, Division of Scientific
Review National Institute of Child Health
And Human Development, 6710B Bethesda
Drive, Bethesda, MD 20892, 301.806.2515,
chatterm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 9, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–02961 Filed 2–13–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorder and Stroke Special
Emphasis Panel; Recording and Modulation
in the Human CNS.
Date: March 13, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Crystal City Hotel, 1800
Jefferson Davis Highway, Arlington, VA
22202.
E:\FR\FM\14FEN1.SGM
14FEN1
Agencies
[Federal Register Volume 82, Number 29 (Tuesday, February 14, 2017)]
[Notices]
[Page 10583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02961]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The [[[ REASON TO CLOSE TEXT IS MISSING ]]] and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the [[[ REASON TO CLOSE TEXT IS
MISSING ]]], the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel.
Date: March 3, 2017.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: Bethesda North Marriott Hotel and Conference Center,
Bethesda, MD 20892750.
Contact Person: Minki Chatterji, Scientific Review
Administrator, Division of Scientific Review, National Institute of
Child Health and Human Development, 6710B Bethesda Drive, Bethesda,
MD 20892, 301.806.2515, chatterm@csr.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Best Pharmaceutical for Children
Act (BPCA) Data Coordinating Center (DCC).
Date: April 11, 2017.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6710 Rockledge Drive,
Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy, Ph.D., Scientific Review
Administrator, Division of Scientific Review, National Institute of
Child Health and Human Development, 6710B Bethesda Drive, Bethesda,
MD 20892, (301) 435-6680, skandasa@mail.nih.gov.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel; Center for Public Information on
Population Research.
Date: May 5, 2017.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Minki Chatterji, Scientific Review
Administrator, Division of Scientific Review National Institute of
Child Health And Human Development, 6710B Bethesda Drive, Bethesda,
MD 20892, 301.806.2515, chatterm@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: February 9, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02961 Filed 2-13-17; 8:45 am]
BILLING CODE 4140-01-P